Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis
- PMID: 18302012
- DOI: 10.1007/s10753-008-9057-3
Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis
Abstract
Aims: The aim of this research is to study the effects of traditional Chinese medicine on endotoxin and its receptors in rats with nonalcoholic steatohepatitis (NASH).
Methods: Fifty-six SD rats were divided into seven groups. All the animals were fed high fatty diet for 12 weeks. Rats with non-alcoholic steatohepatitis (NASH) were treated with traditional Chinese medicine according to low-dose, middle-dose, high-dose and Lipitor from fifth week. All rats were killed at the end of 12th week. The liver pathology changes were observed under light microscope. The levels of serum lipoid, alanine aminotransferase (ALT), endotoxin (ET), tumor necrosis factor-alpha (TNF-alpha) and interleukine-1beta (IL-1beta) were determined. The expressions of CD14 and nuclear transcriptional factor kappaB (NF-kappaB) were observed by immunohistochemistry. The expressions of lipopolysaccharide binding protein (LBP), toll-like receptor-4 (TLR-4), myeloid differentiation-2 (MD-2) and induced nitric oxide synthase (iNOS) mRNA were detected by the reverse transcription polymerase chain reaction (RT-PCR).
Results: The levels of serum endotoxin in the middle dose group (0.0225 +/- 0.0112 EU/l) were lower than those in high fatty diet model group (0.2249 +/- 0.0982 EU/l) at 12th week, the difference was significant (P < 0.01). In the middle dose group, mean values of serum TNF-alpha and IL-1beta levels decreased dramatically (1.604 +/- 0.302 ng/ml and 0.052 +/- 0.024 ng/ml) compared with those in the high fatty diet model group (4.029 +/- 1.180 ng/ml and 14.944 +/- 0.491 ng/ml; P < 0.01 and P < 0.01). The expressions of CD14 and NF-kappaB in the middle dose group decreased compared with those in the high fatty diet model group. The expressions of LBP mRNA (0.284 +/- 0.105) and TLR-4 mRNA (0.290 +/- 0.123) in the middle dose group down regulated compared with those in the high fatty diet model group (1.060 +/- 0.158 and 1.261 +/- 0.368; P < 0.01 and P < 0.01). In the middle dose group MD-2 and iNOS gene expressions were 0.132 +/- 0.058 and 0.164 +/- 0.061, respectively, which were significantly lower compared with the high fatty diet model group (0.795 +/- 0.294 and 1.029 +/- 0.388; P < 0.01 and P < 0.01).
Conclusions: The mechanism of non-alcoholic steatohepatitis (NASH) maybe related to increasing the levels of serum endotoxin, upregulating endotoxin receptors of hepatic tissue and enhancing liver inflammatory injury. Traditional Chinese medicine is a good treatment for non-alcoholic steatohepatitis (NASH). It can produce a marked effect via relieving LPS-induced liver injury.
Similar articles
-
Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression.J Pharmacol Exp Ther. 2013 Mar;344(3):646-54. doi: 10.1124/jpet.112.201137. Epub 2012 Dec 31. J Pharmacol Exp Ther. 2013. PMID: 23277536
-
Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.J Gastroenterol Hepatol. 2012 Aug;27(8):1353-61. doi: 10.1111/j.1440-1746.2012.07123.x. J Gastroenterol Hepatol. 2012. PMID: 22432744
-
ANTI-INFLAMMATORY ACTIVITY OF PLATYCODIN D ON ALCOHOL-INDUCED FATTY LIVER RATS VIA TLR4-MYD88-NF-κB SIGNAL PATH.Afr J Tradit Complement Altern Med. 2016 Jul 3;13(4):176-183. doi: 10.21010/ajtcam.v13i4.23. eCollection 2016. Afr J Tradit Complement Altern Med. 2016. PMID: 28852734 Free PMC article.
-
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.J Toxicol Sci. 2007 Dec;32(5):453-68. doi: 10.2131/jts.32.453. J Toxicol Sci. 2007. PMID: 18198478 Review.
-
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.Crit Rev Food Sci Nutr. 2019;59(sup1):S116-S129. doi: 10.1080/10408398.2018.1544542. Epub 2018 Dec 22. Crit Rev Food Sci Nutr. 2019. PMID: 30580553 Review.
Cited by
-
Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.Lipids Health Dis. 2015 Aug 6;14:85. doi: 10.1186/s12944-015-0082-6. Lipids Health Dis. 2015. PMID: 26242978 Free PMC article.
-
Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.Dig Dis Sci. 2011 May;56(5):1524-34. doi: 10.1007/s10620-010-1447-3. Epub 2010 Nov 3. Dig Dis Sci. 2011. PMID: 21046243
-
CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy.World J Hepatol. 2013 Apr 27;5(4):189-95. doi: 10.4254/wjh.v5.i4.189. World J Hepatol. 2013. PMID: 23671723 Free PMC article.
-
Effects of Ganfukang on expression of connective tissue growth factor and focal adhesion kinase/protein kinase B signal pathway in hepatic fibrosis rats.Chin J Integr Med. 2014 Jun;20(6):438-44. doi: 10.1007/s11655-013-1597-1. Epub 2013 Aug 29. Chin J Integr Med. 2014. PMID: 23990393
-
Investigating the expression of CD180, LY96, VCAM-1, and CSF2RB in the lipopolysaccharide response pathway across different liver cirrhosis etiologies.Mol Biol Rep. 2025 Jun 30;52(1):658. doi: 10.1007/s11033-025-10780-0. Mol Biol Rep. 2025. PMID: 40586795
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous